206 related articles for article (PubMed ID: 24145349)
1. BCCIP suppresses tumor initiation but is required for tumor progression.
Huang YY; Dai L; Gaines D; Droz-Rosario R; Lu H; Liu J; Shen Z
Cancer Res; 2013 Dec; 73(23):7122-33. PubMed ID: 24145349
[TBL] [Abstract][Full Text] [Related]
2. Roles of BCCIP deficiency in mammary tumorigenesis.
Droz-Rosario R; Lu H; Liu J; Liu NA; Ganesan S; Xia B; Haffty BG; Shen Z
Breast Cancer Res; 2017 Oct; 19(1):115. PubMed ID: 29047390
[TBL] [Abstract][Full Text] [Related]
3. BCCIP regulates homologous recombination by distinct domains and suppresses spontaneous DNA damage.
Lu H; Yue J; Meng X; Nickoloff JA; Shen Z
Nucleic Acids Res; 2007; 35(21):7160-70. PubMed ID: 17947333
[TBL] [Abstract][Full Text] [Related]
4. Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
Dixit U; Liu Z; Pandey AK; Kothari R; Pandey VN
BMC Cancer; 2014 Dec; 14():925. PubMed ID: 25487856
[TBL] [Abstract][Full Text] [Related]
5. Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression.
Thomas WD; Chen J; Gao YR; Cheung B; Koach J; Sekyere E; Norris MD; Haber M; Ellis T; Wainwright B; Marshall GM
Oncogene; 2009 Apr; 28(13):1605-15. PubMed ID: 19234491
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.
Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW
Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539
[TBL] [Abstract][Full Text] [Related]
7. BCCIP is required for the nuclear localization of the p21 protein.
Fan J; Wray J; Meng X; Shen Z
Cell Cycle; 2009 Sep; 8(18):3019-24. PubMed ID: 19713748
[TBL] [Abstract][Full Text] [Related]
8. High Expression of BCCIP β Can Promote Proliferation of Esophageal Squamous Cell Carcinoma.
Chen L; Ni S; Li M; Shen C; Lin Z; Ouyang Y; Xia F; Liang L; Jiang W; Ni R; Zhang J
Dig Dis Sci; 2017 Feb; 62(2):387-395. PubMed ID: 27995408
[TBL] [Abstract][Full Text] [Related]
9. p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma.
Wei Y; Maximov V; Morrissy SA; Taylor MD; Pallas DC; Kenney AM
Mol Cancer Res; 2019 Jan; 17(1):186-198. PubMed ID: 30224541
[TBL] [Abstract][Full Text] [Related]
10. SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development.
Shi X; Wang Q; Gu J; Xuan Z; Wu JI
Oncogene; 2016 Nov; 35(44):5746-5758. PubMed ID: 27065321
[TBL] [Abstract][Full Text] [Related]
11. Functional loss of a noncanonical BCOR-PRC1.1 complex accelerates SHH-driven medulloblastoma formation.
Kutscher LM; Okonechnikov K; Batora NV; Clark J; Silva PBG; Vouri M; van Rijn S; Sieber L; Statz B; Gearhart MD; Shiraishi R; Mack N; Orr BA; Korshunov A; Gudenas BL; Smith KS; Mercier AL; Ayrault O; Hoshino M; Kool M; von Hoff K; Graf N; Fleischhack G; Bardwell VJ; Pfister SM; Northcott PA; Kawauchi D
Genes Dev; 2020 Sep; 34(17-18):1161-1176. PubMed ID: 32820036
[TBL] [Abstract][Full Text] [Related]
12. Roles of BCCIP in chromosome stability and cytokinesis.
Meng X; Fan J; Shen Z
Oncogene; 2007 Sep; 26(43):6253-60. PubMed ID: 17452982
[TBL] [Abstract][Full Text] [Related]
13. Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas.
Liu J; Lu H; Ohgaki H; Merlo A; Shen Z
BMC Cancer; 2009 Aug; 9():268. PubMed ID: 19653894
[TBL] [Abstract][Full Text] [Related]
14. Requirement of mouse BCCIP for neural development and progenitor proliferation.
Huang YY; Lu H; Liu S; Droz-Rosario R; Shen Z
PLoS One; 2012; 7(1):e30638. PubMed ID: 22292003
[TBL] [Abstract][Full Text] [Related]
15. BCCIP is required for nucleolar recruitment of eIF6 and 12S pre-rRNA production during 60S ribosome biogenesis.
Ye C; Liu B; Lu H; Liu J; Rabson AB; Jacinto E; Pestov DG; Shen Z
Nucleic Acids Res; 2020 Dec; 48(22):12817-12832. PubMed ID: 33245766
[TBL] [Abstract][Full Text] [Related]
16. WIP1 enhances tumor formation in a sonic hedgehog-dependent model of medulloblastoma.
Doucette TA; Yang Y; Pedone C; Kim JY; Dubuc A; Northcott PD; Taylor MD; Fults DW; Rao G
Neurosurgery; 2012 Apr; 70(4):1003-10; discussion 1010. PubMed ID: 22037313
[TBL] [Abstract][Full Text] [Related]
17. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
Northcott PA; Fernandez-L A; Hagan JP; Ellison DW; Grajkowska W; Gillespie Y; Grundy R; Van Meter T; Rutka JT; Croce CM; Kenney AM; Taylor MD
Cancer Res; 2009 Apr; 69(8):3249-55. PubMed ID: 19351822
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of the BCCIP gene for breast cancer susceptibility in breast/ovarian cancer families.
Bonache S; Gutierrez-Enriquez S; Tenés A; Masas M; Balmaña J; Diez O
Gynecol Oncol; 2013 Nov; 131(2):460-3. PubMed ID: 23911796
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of the transactivation activity of p53 by BCCIP down-regulation.
Meng X; Yue J; Liu Z; Shen Z
J Biol Chem; 2007 Jan; 282(3):1570-6. PubMed ID: 17135243
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis suppression by somatic cell transfer of Bcl-2 promotes Sonic hedgehog-dependent medulloblastoma formation in mice.
McCall TD; Pedone CA; Fults DW
Cancer Res; 2007 Jun; 67(11):5179-85. PubMed ID: 17545597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
